BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6187016)

  • 1. Antibodies to Escherichia coli K and O antigens in protection against acute pyelonephritis.
    Kaijser B; Larsson P; Nimmich W; Söderström T
    Prog Allergy; 1983; 33():275-88. PubMed ID: 6187016
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.
    Kaijser B; Larsson P; Olling S; Schneerson R
    Infect Immun; 1983 Jan; 39(1):142-6. PubMed ID: 6337094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
    Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
    J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical progress: immunobiology and genetic factors in the pathogenesis of pyelonephritis.
    Hemstreet GP; Cruse JM; Feye GL
    Surv Synth Pathol Res; 1984; 3(2):93-111. PubMed ID: 6209767
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimation of Escherichia coli antibodies in urinary tract infection: a review and perspective.
    Neter E
    Kidney Int Suppl; 1975 Aug; 4():S23-7. PubMed ID: 1104978
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production of O antigens and antibodies during urinary tract infections due to Escherichia coli (author's transl)].
    Fries D; Renault L; Mathieu D; Charpentier B; Guerin D; Jacques L
    Nouv Presse Med; 1979 Mar; 8(15):1239-43. PubMed ID: 375188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [E. coli serum antibodies in pyelonephritis: their detection with monovalent O-antigens of known blood groups, with polyvalent antigens, isolated from patients' urine].
    Túri S; Petheö G; Boda K; Temesvári P; Czirók E
    Acta Paediatr Acad Sci Hung; 1979; 20(2-3):199-209. PubMed ID: 397713
    [No Abstract]   [Full Text] [Related]  

  • 8. Peroral immunization of healthy adults with live Escherichia coli O4K12 bacteria. Antibody response as measured in serum and secretions.
    Kaijser B
    Int Arch Allergy Appl Immunol; 1983; 70(2):164-8. PubMed ID: 6337107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The host-parasite relationship in urinary tract infections.
    Hanson LA; Ahlstedt S; Jodal U; Kaijser B; Larsson P; Lidin-Janson G; Lincoln K; Lindberg U; Mattsby I; Olling S; Peterson H; Sohl A
    Kidney Int Suppl; 1975 Aug; 4():S28-34. PubMed ID: 1104979
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
    Mattsby-Baltzer I; Hanson LA; Olling S; Kaijser B
    Infect Immun; 1982 Feb; 35(2):647-53. PubMed ID: 7035370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological aspects of pyelonephritis.
    Hanson LA; Ahlstedt S; Fasth A; Hagberg M; Kaijser B; Mattsby-Baltzer I; Svanborg-Eden C
    Contrib Nephrol; 1979; 16():16-21. PubMed ID: 380897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological aspects of pyelonephritis].
    Spineter-Sokołowska E; Sulima-Gillow A; Hebanowski M; Manitius A
    Pol Tyg Lek; 1980 Jun; 35(26):955-8. PubMed ID: 6999476
    [No Abstract]   [Full Text] [Related]  

  • 13. The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.
    Smith JW; Kaijser B
    J Clin Invest; 1976 Aug; 58(2):276-81. PubMed ID: 783196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
    Kaijser B; Larsson P; Olling S
    Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of indirect hemagglutination test with polyvalent E. coli O antigens to diagnosis of pyelonephritis (author's transl)].
    Strohm WD; Osten O; Schoeppe B; Schoeppe W
    Med Klin; 1976 Aug; 71(35):1372-6. PubMed ID: 785184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immuno-bacteriological aspects of pathogenesis of pyelonephritis in children].
    Glezerov VZ; Sivochub MI
    Urol Nefrol (Mosk); 1976; (1):12-4. PubMed ID: 793133
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli K antigen.
    Kaijser B; Vahlne G
    Zentralbl Bakteriol Orig A; 1979 Apr; 243(2-3):271-88. PubMed ID: 377857
    [No Abstract]   [Full Text] [Related]  

  • 19. [New findings in the pathogenesis of pyelonephritis].
    Gruev I
    Vutr Boles; 1984; 23(5):17-20. PubMed ID: 6395491
    [No Abstract]   [Full Text] [Related]  

  • 20. Initiation of clinical pyelonephritis--the role of P-fimbriae-mediated bacterial adhesion.
    Svenson SB; Källenius G; Korhonen TK; Möllby R; Roberts JA; Tullus K; Winberg J
    Contrib Nephrol; 1984; 39():252-72. PubMed ID: 6146493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.